Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts

Detalhes bibliográficos
Autor(a) principal: Madrigal-Chávez, Rafael
Data de Publicação: 2023
Outros Autores: Ruíz-Pompa, Kristal, Márquez-López , Anahí, Valencia Flores, Dora Cecilia, Chávez-Parga, Ma. Del Carmen, González-Hernández, Juan Carlos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/211880
Resumo: Ellagic acid (EA) is a phenolic biomolecule. For its biosynthesis, a source of ellagitannins is required, such as strawberries and yeasts, as precursors of the tannase and β-glucosidase enzymes responsible for hydrolysis of ellagitannins. Two experimental mixture designs were applied., varying the yeast concentration and the number of ellagitannins in the culture medium, evaluating the enzymatic activity and ellagic acid biosynthesis. Aiming to find the optimal compositions of the non-conventional yeasts assessed in the research to biosynthesize ellagic acid feasibly and efficiently using a response surface performing the statistical analysis in the StatGraphics® program for obtaining a higher yield and optimizing the ellagic acid synthesis process, the results indicate that the strains Candida parapsilosis ITM LB33 and Debaryomyces hansenii ISA 1510 have a positive effect on the synthesis of ellagic acid, since as its concentration increases in the mixture the concentration of ellagic acid in the medium also increases; on the other hand, the addition of Candida utilis ITM LB02 causes a negative effect, resulting in the compositions of 0.516876, 0.483124 and 2.58687E-9 respectively, for a treatment under the same conditions, an optimal value of ellagic acid production would be obtained. With an approximate value of 7.33036 mg/mL.
id USP-31_c4887f0bfdd91950b0c8eba79142f3f4
oai_identifier_str oai:revistas.usp.br:article/211880
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeastsEllagic acidYeastsBioreactorOptimizationEllagic acid (EA) is a phenolic biomolecule. For its biosynthesis, a source of ellagitannins is required, such as strawberries and yeasts, as precursors of the tannase and β-glucosidase enzymes responsible for hydrolysis of ellagitannins. Two experimental mixture designs were applied., varying the yeast concentration and the number of ellagitannins in the culture medium, evaluating the enzymatic activity and ellagic acid biosynthesis. Aiming to find the optimal compositions of the non-conventional yeasts assessed in the research to biosynthesize ellagic acid feasibly and efficiently using a response surface performing the statistical analysis in the StatGraphics® program for obtaining a higher yield and optimizing the ellagic acid synthesis process, the results indicate that the strains Candida parapsilosis ITM LB33 and Debaryomyces hansenii ISA 1510 have a positive effect on the synthesis of ellagic acid, since as its concentration increases in the mixture the concentration of ellagic acid in the medium also increases; on the other hand, the addition of Candida utilis ITM LB02 causes a negative effect, resulting in the compositions of 0.516876, 0.483124 and 2.58687E-9 respectively, for a treatment under the same conditions, an optimal value of ellagic acid production would be obtained. With an approximate value of 7.33036 mg/mL.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-05-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21188010.1590/s2175-97902023e21508Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21508Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21508Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e215082175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/211880/194712https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessMadrigal-Chávez, RafaelRuíz-Pompa, KristalMárquez-López , AnahíValencia Flores, Dora CeciliaChávez-Parga, Ma. Del CarmenGonzález-Hernández, Juan Carlos2023-06-02T20:56:44Zoai:revistas.usp.br:article/211880Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-06-02T20:56:44Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts
title Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts
spellingShingle Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts
Madrigal-Chávez, Rafael
Ellagic acid
Yeasts
Bioreactor
Optimization
title_short Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts
title_full Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts
title_fullStr Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts
title_full_unstemmed Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts
title_sort Optimization of the ellagic acid synthesis process at the bioreactor level using non-conventional yeasts
author Madrigal-Chávez, Rafael
author_facet Madrigal-Chávez, Rafael
Ruíz-Pompa, Kristal
Márquez-López , Anahí
Valencia Flores, Dora Cecilia
Chávez-Parga, Ma. Del Carmen
González-Hernández, Juan Carlos
author_role author
author2 Ruíz-Pompa, Kristal
Márquez-López , Anahí
Valencia Flores, Dora Cecilia
Chávez-Parga, Ma. Del Carmen
González-Hernández, Juan Carlos
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Madrigal-Chávez, Rafael
Ruíz-Pompa, Kristal
Márquez-López , Anahí
Valencia Flores, Dora Cecilia
Chávez-Parga, Ma. Del Carmen
González-Hernández, Juan Carlos
dc.subject.por.fl_str_mv Ellagic acid
Yeasts
Bioreactor
Optimization
topic Ellagic acid
Yeasts
Bioreactor
Optimization
description Ellagic acid (EA) is a phenolic biomolecule. For its biosynthesis, a source of ellagitannins is required, such as strawberries and yeasts, as precursors of the tannase and β-glucosidase enzymes responsible for hydrolysis of ellagitannins. Two experimental mixture designs were applied., varying the yeast concentration and the number of ellagitannins in the culture medium, evaluating the enzymatic activity and ellagic acid biosynthesis. Aiming to find the optimal compositions of the non-conventional yeasts assessed in the research to biosynthesize ellagic acid feasibly and efficiently using a response surface performing the statistical analysis in the StatGraphics® program for obtaining a higher yield and optimizing the ellagic acid synthesis process, the results indicate that the strains Candida parapsilosis ITM LB33 and Debaryomyces hansenii ISA 1510 have a positive effect on the synthesis of ellagic acid, since as its concentration increases in the mixture the concentration of ellagic acid in the medium also increases; on the other hand, the addition of Candida utilis ITM LB02 causes a negative effect, resulting in the compositions of 0.516876, 0.483124 and 2.58687E-9 respectively, for a treatment under the same conditions, an optimal value of ellagic acid production would be obtained. With an approximate value of 7.33036 mg/mL.
publishDate 2023
dc.date.none.fl_str_mv 2023-05-08
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/211880
10.1590/s2175-97902023e21508
url https://www.revistas.usp.br/bjps/article/view/211880
identifier_str_mv 10.1590/s2175-97902023e21508
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/211880/194712
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21508
Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023); e21508
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023); e21508
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222918052937728